CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts-Reference-Cited by-同舟云学术

CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts

Published:2019-05 Issue:5 Volume:21 Page:582-588
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Laurent Lucie,Sefrioui David,Bignon Anne-Laure,Parzy Aurélie,Sidali Sabrina,Hassine Mélanie,Gangloff Alice,Galais Marie-Pierre,Bouhier-Leporrier Karine,Michel Pierre,Di Fiore Frédéric

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference22 articles.

1. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal;Ballehaninna;J Gastrointest Oncol,2012

2. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer;Tempero;Cancer Res,1987

3. Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation;Katz;Ann Surg Oncol,2010

4. Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trials;Bauer;Cancer,2013

5. CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials;Maisey;Br J Cancer,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CA19-9 and CEA biosensors in pancreatic cancer;Clinica Chimica Acta;2024-02

2. Ultrasensitive immunosensor for monitoring of CA 19-9 pancreatic cancer marker using electrolyte-gated TiS3 nanoribbons field-effect transistor;Talanta;2023-05

3. Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms;Pancreatology;2023-03

4. Liquid biopsy leads to a paradigm shift in the treatment of pancreatic cancer;World Journal of Gastroenterology;2022-12-14

5. Role of Neoplastic Markers in Pancreatic Adenocarcinoma;Journal of Clinical Medicine;2022-11-02